Wednesday, October 4, 2023
Wednesday, October 4, 2023

Contact: 561.316.3330

Hicuity Health Partner Expands Its Relationship with Sarah Bush Lincoln Health Center

Hicuity Health, the nation’s leading provider of high-acuity telemedicine services, is expanding its relationship with Sarah Bush Lincoln with the implementation of inpatient telemetry services. Sarah Bush Lincoln has partnered with Hicuity Health for tele-ICU services since 2015. The success of this ongoing critical care collaboration influenced the decision to extend the partnership to include the new telemetry services.

Hicuity Health’s Remote Cardiac Telemetry monitoring provides hospitals with 24/7 monitoring by trained and certified telemetry technicians located in dedicated technology-enabled care centers. Hicuity’s nurse-managed technicians monitor cardiac at-risk patients throughout the hospital, identifying cardiac abnormalities, and then urgently reporting them to the bedside team. Partnering with Hicuity Health’s remote monitoring service engages trained monitoring of patient waveforms and allows bedside nurses to maintain their focus on patient care rather than focusing on computer monitors and responding to false alarms.

“As a tele-ICU partner, we have been impressed by Hicuity Health’s support and collaborative approach. The expansion of our relationship to include telemetry services is a direct result of our years of experience with Hicuity. Simply put, we wanted to ensure that we were working with a team that would be an expert partner to our clinical team,” Sandra Miller, SBL VP Patient Care Continuum, CNO, said. “The decision to expand the relationship to include remote telemetry services is a strategic decision from both an operational and clinical perspective.”

“We are pleased to extend our long-term relationship with Sarah Bush Lincoln to include telemetry services,” said Lou Silverman, Chief Executive Officer of Hicuity Health. “Its addition of Hicuity Health’s Remote Cardiac Telemetry services emphasizes the hospital’s commitment to providing its staff with the support needed to ensure high quality patient care.”

Medical Device News Magazinehttps://infomeddnews.com
Our publication is dedicated to bringing our readers the latest medical device news. We are proud to boast that our subscribers include medical specialists, device industry executives, investors, and other allied health professionals, as well as patients who are interested in researching various medical devices. We hope you find value in our easy-to-read publication and its overall purpose and objectives! Medical Device News Magazine is a division of PTM Healthcare Marketing, Inc. Pauline T. Mayer is the managing editor.

More News!

Centinel Spine’s prodisc ® Continues to Change Lives After Over 30 Years and 250,000 Total Disc Replacement Implantations

The prodisc lumbar and cervical technologies will be highlighted by Centinel Spine at the upcoming 2023 annual EUROSPINE meeting and congress in Frankfurt, Germany (October 4-6, 2023). The prodisc technology portfolio now includes four cervical and two lumbar devices—5 approved by the FDA—and has been validated with a reported reoperation rate of less than 1%.

Amber Implants Announces Start of Clinical Trial with VCFix® Spinal System

This first-in-human clinical trial will assess the safety and effectiveness of the VCFix® Spinal System implant for patients suffering from vertebral compression fractures. The implant is provided with a user-friendly, single-use sterile surgical kit, ensuring perfect traceability and reducing the risk of infection. 

RaySearch Deepens Collaboration with P-Cure

The expanded collaboration will enable users of the P-Cure proton therapy system to use RayStation and RayCare in a seamlessly integrated environment. The P-Cure system is a gantry-less seated proton system, designed to fit within linac vaults, that has recently been cleared by the FDA. It is used clinically by the Hadassah Medical Center in Jerusalem – the only proton facility in the Middle East – to treat CNS, head and neck, thoracic and pancreatic malignancies.

Edinburgh-based Med-tech Firm in MBO to Expand Into New Markets and Technologies

The acquisition will enable Novarum to build on its strong lateral flow test customer base and extend into adjacent markets. 

Biomic Sciences Issues Voluntary Nationwide Recall of ION* Sinus Support, ION* Biome Sinus, and Restore Sinus Spray Products Due to Microbial Contamination

Risk Statement: In the population most at risk, patients or individuals who recently underwent nasal or sinus surgery, there is a reasonable probability that the use of the affected product could potentially result in severe or life-threatening adverse events such as bacteremia or fungemia, invasive bacterial or fungal rhinosinusitis, or disseminated fungal infection. To date, Biomic Sciences has not received any reports of adverse events related to this product.

By using this website you agree to accept Medical Device News Magazine Privacy Policy